162
Participants
Start Date
February 29, 2012
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
Caffeine, paracetamol, cephalexin, or ibuprofen
The study has 4 sub-parts (one for each of 4 drugs), each sub-part has a crossover design. In this arm, the volunteer will be given one oral dose of 300 mg caffeine, 500 mg paracetamol, 500 mg cephalexin, or 400 mg ibuprofen and will be told that they are receiving the active drug.
Placebo (caffeine, paracetamol, cephalexin, or ibuprofen)
The study has 4 sub-parts (one for each of 4 drugs), each sub-part has a crossover design. In this arm, the volunteer will be given one oral dose of 300 mg caffeine, 500 mg paracetamol, 500 mg cephalexin, or 400 mg ibuprofen and will be told that they are receiving a placebo.
King Faisal Specialist Hospital & Research Center, Riyadh
King Faisal Specialist Hospital & Research Center
OTHER